Home
Tessa Therapeutics Ltd.

Tessa Therapeutics Ltd. Market Share Analysis for May 2026

Better Workers, Better Family Members, Better Friends, Better Neighbors, Better Strangers, and Better Cinners Our goal is to make an everlasting difference…

Industry: N/A

Domaintessacell.com

Year Founded2012

Employees51 - 200

Annual Revenue$25M - $50M

Tessa Therapeutics Ltd.

Tessa Therapeutics Ltd. (including company regionals)

tessacell.com

See more website traffic and engagement information

Tessa Therapeutics Ltd. Revenue up to May 2026 is 25M - 50M

revenue generated by Tessa Therapeutics Ltd. top domains

Tessa Therapeutics Ltd. top domains revenue over 3 years

Revenue for Tessa Therapeutics Ltd. top domains

tessacell.com25M - 50M

See more with Sales Intelligence

Total visits to Tessa Therapeutics Ltd.'s top domains

Understand Tessa Therapeutics Ltd. market share and potential market reach.

Total visits last 3 months

No Data to Display

Avg. visit duration in Tessa Therapeutics Ltd.'s top domains

Analyze Tessa Therapeutics Ltd. engagement metrics.

Average visit duration last 3 months

No Data to Display

Avg. pageviews on Tessa Therapeutics Ltd.'s top domains

See how Tessa Therapeutics Ltd. keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

No Data to Display

Tessa Therapeutics Ltd. top competitors by domain

Looks like there’s not enough data here

No Data to Display

Top technologies used by Tessa Therapeutics Ltd.

These are the website technologies, by industry, used by Tessa Therapeutics Ltd. top domains

Payment & Currencies (5)

Cart Functionality

Conversion & Analytics (3)

Google Analytics

Mobile (3)

Meta Viewport

Advertising (2)

Google Adsense

More Technologies

8

See all

News & Signals from Tessa Therapeutics Ltd.

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsTessa Therapeutics receives financing of $200M.Tessa Therapeutics dissolves after raising more than $200M.

NewsPolaris Partners invested into Tessa Therapeutics $126M on Jun 1st '22.Tessa’s latest fundraising success came in June 2022, in which the Singaporean biotech raised $126 million in a Series A financing round led by Polaris Partners, a US-based biopharma and healthcare venture capital firm, with participation from existing investors.

NewsTessa Therapeutics launched safety and efficacy data from a study of off-the-shelf CD30.CAR EBVST therapy on Jun 16th '23.Tessa Therapeutics Ltd. (Tessa), a clinical-stage cell therapy company developing next-generation cancer treatments for hematological malignancies and solid tumors, today announced promising safety and efficacy data from a study of its off-the-shelf CD30.CAR EBVST therapy (TT11X) in patients with relapsed or refractory (R/R) Hodgkin lymphoma.